Michael Yu Dechao, chairman and co-founder of Innovent Biologics. Photo: Edmond So
Hong Kong listed Innovent Biologics believes it can help usher in a ‘game changer’ for drug prices in China
- Innovent Biologics, one of the first batch of firms listed in Hong Kong under the new listing regime, jumped 18.6 per cent to close at HK$16.58 in debut trade on Wednesday
Topic |
Pharmaceuticals
Michael Yu Dechao, chairman and co-founder of Innovent Biologics. Photo: Edmond So